Thus, our findings explain the mechanisms of the p53-dependent effect of KLF5 on liver cancer cell EMT and suggest that KLF5 loss is a valuable diagnostic and therapeutic target for invasive liver cancer, and potentially for other cancers associated with p53 loss or mutation. This evidence concerns the gene TP53 and cancer.